HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NSF Targets Late 2014 For Natural Cosmetic Standard

This article was originally published in The Rose Sheet

Executive Summary

NSF International provides an update on the development of its NSF/ANSI 384 standard for natural cosmetics. Though it has its own standard and seal program, the Natural Products Association is a participant in NSF’s development process with a seat on its joint committee.

You may also be interested in...

Don't Market Yourself Into A Corner With Natural Claims – UL Exec

Natural personal care is a compelling opportunity, but "don't expose yourself for marketing points," UL exec Matthew Cerundolo told HBA Global Expo attendees June 10 during a session on regulatory and safety compliance for natural products. With debate continuing around natural product standards and minimal regulatory involvement from agencies in the U.S. to date, legal risks abound, he noted.

Audio Feature: FDA Monitoring Cosmetic Claims, But Litigation Remains Biggest Threat

Attorney Steven Shapiro, a partner at Ullman, Shapiro & Ullman, LLP, offers perspective on what he considers some of the biggest challenges cosmetics companies face in the current regulatory and legal landscape, specifically when it comes to crafting claims. Story features audio clips from the attorney’s interview with “The Rose Sheet.”

In Brief: ICMAD On OTC Monograph System; NSF Natural Standard; More

The Independent Cosmetic Manufacturers and Distributors recognizes the need for improvement but urged FDA to maintain ingredient approval under its OTC drug monograph system at the agency’s March 26 hearing; NSF provides an updated timeline for its natural personal-care standard; more news in brief.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts